Regular researcher at the CHU de Québec Research Center, and professor in the Department of Psychiatry-Neurosciences, Dr. Guertin’s work focuses on paralysis. He discovered a pharmacological treatment called Spinalon that can powerfully activate the locomotor neurons of the spinal cord in paraplegic animals, despite complete injury. This discovery is patented and clinical trials (phase I-IIa) in humans have been successfully completed. This important advance was highlighted in various reports, notably on Radio-Canada television and radio.

Improve the quality of life of people with health problems related to reduced mobility and paralysis

Studies in Dr. Guertin’s lab indicate that, following a spinal cord injury, the spinal neural circuits on either side of the lesion remain ‘alive’, but undergo many modifications at the cellular and intracellular level. Intrinsic properties are studied, as well as ‘plasticity’ type changes in cell genetics and the organization of neural networks. Secondary problems also occur in other biological systems of the body (metabolic, cardiovascular, muscular, dermatological, digestive, etc.) mainly related to mobility impairment and its effects on the metabolism in general. Dr. Guertin’s long-term goal is to develop methods, including pharmacological treatments able to prevent these various changes at the neuronal and systemic and metabolic level to improve these individual’s various physical functions.

Develop treatments capable of restoring functions in the locomotor, reproductive, dermatological and eliminatory systems

To better understand the systems that need to be pharmacologically reactivated or modulated, he is currently studying transmembrane receptors in the spinal cord of the lumbar region. Certain receptor subfamilies seem to be of interest, because they are involved in the actual genesis of several so-called stereotyped functions controlled by the spinal cord – walking, urination, defecation, and ejaculation. In parallel, he is working on optimizing a new treatment aimed at automatically inducing ejaculation in subjects with anejaculation, in relation to lesions of the central nervous system.

CHUL
2705, boulevard Laurier
P-0-9800
Québec, Québec
Canada G1V 4G2

Latest news

Data not available

102 entries « 2 of 11 »

Chilibeck PD, Guertin PA

Locomotor Training and Factors Associated with Blood Glucose Regulation After Spinal Cord Injury.

Journal Article

Curr Pharm Des, 23 (12), pp. 1834-1844, 2017, ISSN: 1381-6128.

Abstract | Links:

Radhakrishna M, Steuer I, Prince F, Roberts M, Mongeon D, Kia M, Dyck S, Matte G, Vaillancourt M, Guertin PA

Double-Blind, Placebo-Controlled, Randomized Phase I/IIa Study (Safety and Efficacy) with Buspirone/Levodopa/Carbidopa (SpinalonTM) in Subjects with Complete AIS A or Motor-Complete AIS B Spinal Cord Injury.

Journal Article

Curr Pharm Des, 23 (12), pp. 1789-1804, 2017, ISSN: 1381-6128.

Abstract | Links:

Sylos-Labini F, Zago M, Guertin PA, Lacquaniti F, Ivanenko YP

Muscle Coordination and Locomotion in Humans.

Journal Article

Curr Pharm Des, 23 (12), pp. 1821-1833, 2017, ISSN: 1381-6128.

Abstract | Links:

Diaz-Rios M, Guertin PA, Rivera-Oliver M

Neuromodulation of Spinal Locomotor Networks in Rodents.

Journal Article

Curr Pharm Des, 23 (12), pp. 1741-1752, 2017, ISSN: 1381-6128.

Abstract | Links:

Minassian K, Hofstoetter US, Dzeladini F, Guertin PA, Ijspeert A

The Human Central Pattern Generator for Locomotion: Does It Exist and Contribute to Walking?

Journal Article

Neuroscientist, 23 (6), pp. 649-663, 2017, ISSN: 1073-8584.

Abstract | Links:

Guertin PA

Readily implementable measures to improve the safety of dermatological, skin care and anti-ageing products

Journal Article

J Dermatol Clin Res, 4 (5), pp. 1088, 2016, ISSN: 2373-9371.

Guertin PA

Stricter Regulations and Adaptive Clinical Trial Design for Safer and more Effective Skin Care Products

Journal Article

J Dermatol Clin Res, 4 (5), pp. 1086, 2016, ISSN: 2373-9371.

Guertin PA

Drug safety of skin care products - neuro- and non-neuromediated actions

Journal Article

Global drugs and therapeutics, 1 (1), pp. 1-2, 2016, ISSN: 2399-9098.

Guertin PA

Epidemiology of dermatological diseases - aging, metabolic diseases and beyond

Journal Article

Global drugs and therapeutics, 1 (1), pp. 1-2, 2016, ISSN: 2399-9098.

| Links:

Guertin PA

New avenues for reducing intensive care needs in patients with chronic spinal cord injury.

Journal Article

World J Crit Care Med, 5 (4), pp. 201-203, 2016, ISSN: 2220-3141.

Abstract | Links:

102 entries « 2 of 11 »
Signaler des ajouts ou des modifications

Active projects

  • A key subset of receptors involved in spinal-mediated biological rhythms., Subvention, Conseil de recherches en sciences naturelles et génie Canada, Subventions à la découverte SD (individuelles et d'équipe), from 2016-04-01 to 2022-03-31
  • Centre de recherche du CHU de Québec - Université Laval, Subvention, Centre hospitalier universitaire de Québec - Université Laval, Centres de recherche affiliés, from 2017-01-01 to 2099-12-31
Data provided by the Université Laval research projects registery